Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine

This review provides an overview of the role of the mineralocorticoid receptor (MR) in inflammation and fibrosis and compares steroidal MR antagonists (MRAs), such as spironolactone and eplerenone, with nonsteroidal MRAs, such as finerenone and esaxerenone.

European Heart Journal